KBC Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-20,794
Closed -$2.4M 1932
2023
Q3
$2.4M Sell
20,794
-63,015
-75% -$6.77M 0.01% 560
2023
Q2
$8.62M Sell
83,809
-64,559
-44% -$6.81M 0.04% 380
2023
Q1
$16.2M Sell
148,368
-146,104
-50% -$16.1M 0.07% 267
2022
Q4
$33.5M Sell
294,472
-76,654
-21% -$6.37M 0.16% 145
2022
Q3
$23M Buy
371,126
+11,554
+3% +$807K 0.12% 186
2022
Q2
$28.7M Sell
359,572
-25,594
-7% -$2.42M 0.14% 173
2022
Q1
$40.5M Buy
385,166
+112,292
+41% +$10.9M 0.16% 156
2021
Q4
$29.4M Sell
272,874
-10,431
-4% -$1.14M 0.1% 212
2021
Q3
$31M Sell
283,305
-42,687
-13% -$4.43M 0.11% 198
2021
Q2
$30.5M Sell
325,992
-24,490
-7% -$2.25M 0.06% 303
2021
Q1
$32.3M Buy
350,482
+155,716
+80% +$13.1M 0.07% 293
2020
Q4
$78.4M Buy
194,766
+108,814
+127% +$8.09M 0.03% 398
2020
Q3
$6.68M Buy
+85,952
New +$5.91M 0.02% 491

Other funds holding HZNP